CRP and systemic sclerosis: However, CRP+ SSc patients had a significantly higher BMI (28.2 vs. 25.8 kg/m2, p = 0.037), used significantly more often glucocorticoids (p = 0.023), significantly less often hydroxychloroquine (p = 0.012) and showed a statistical trend toward having on average an almost 2-year shorter SSc disease duration.